News of Note—Chickenpox outbreak, GeoVax and more

newspaper
In this week's news of note, GeoVax entered a new immunotherapy collaboration. (Pixabay)

Here is some other vaccine news of note for the week:

> A chickenpox outbreak in a North Carolina anti-vaccination hotbed is the state's worst in two decades. The Washington Post article

> GeoVax entered a collaboration with Leidos to test its vaccine candidates in conjunction with Leidos-developed checkpoint inhibitors. Release

> In a preclinical study, a DNA vaccine lowered the buildup of tau and beta-amyloid proteins associated with Alzheimer's disease. Release

Read more on

Suggested Articles

Even as it gears up for phase 3 testing, Moderna has started commercial COVID-19 vaccine manufacturing, its CEO said.

China's AIM Vaccine Group is investing $79 million in a manufacturing and R&D base for its inactivated COVID-19 vaccine candidate.

Some pharma executives have been predicting a COVID-19 vaccine debut by year's end, but Merck CEO Kenneth Frazier doubts that's possible.